Newsletter Current page: 6

This year we once again hosted the annual Investors’ Day and the shareholders’ meetings of the SHS Funds. To our great pleasure, it was again possible this year to hold the event in the presence of the investors. Investors, portfolio representatives, our senior advisors and healthcare experts were invited to the Hotel Krone in the […]

Today, anyone who has to endure painful dental treatment asks their dentist for an injection as a matter of course. But in the case of a first operation with general anaesthesia, many patients probably ask themselves whether they will really not notice anything of the operation and the pain – despite comprehensive information from the […]

SHS is pleased to be able to offer students the opportunity for practical experience within the framework of an internship in 2022 and to provide them with an insight into the private equity sector. We have been pleased to welcome Charlotte Eusterbrock to SHS since mid-November 2021. Charlotte is currently completing her Bachelor’s degree in […]

As part of a strategic partnership, the German healthcare company AMW will in future focus on the development, approval and licensing of biodegradable transdermal delivery systems. The new French partner AdhexPharma is responsible for series production and lifecycle management and brings with it the best prerequisites for this. “We are pleased that our portfolio company […]

Mitral valve regurgitation (leakage) is one of the very common heart diseases. It is estimated that around 25 million patients worldwide suffer from it. CoreMedic GmbH has developed the ChordArt™ mitral valve repair system, a device for the safe repair of the mitral valve. In a broad, two-year patient study, the ChordArt™ system has now […]

In the development of an urgently needed in-vitro diagnostic test for multiple sclerosis, numares AG relies exclusively on the scientific preliminary work of the University of Oxford. numares works with AI and develops multimarker algorithms for diagnostic tests. With the help of the new MS tests, the transitions between different stages of the disease in […]

With the Super High Pressure PTCA Balloon, SIS Medical AG manufactures a top product for interventional cardiology. This high-pressure balloon catheter can be used to treat calcified or severely calcified vessels and also in-stent restenosis. Now SIS is pleased to announce that it has been able to recruit Ron Waksman of MedStar Washington Hospital Center, […]

The last two years have clearly shown how important technical suppliers are to the healthcare industry. SHS is therefore pleased to announce a successful investment in a technologically leading Danish medium-sized company in the supply chain field. Lowenco A/S has been developing, producing and installing high-tech ultra-low temperature storage solutions for the biopharma industry since […]

With its investment in the fast-growing French genomics expert PathoQuest SAS, SHS is investing in neighbouring France for the first time. PathoQuest is a spin-off of the Institut Pasteur, one of the world’s leading centres for basic research in biology and medicine. PathoQuest plays a leading role in Europe in the field of quality control […]

For almost two years now, the Corona pandemic has had a massive impact on our lives and also on the economy. This is shown by the small dampener of 0.3 percentage points that the SHS Medical Technology Index had to accept in 2020. Compared to the economy as a whole, however, this decline is moderate […]

The Leipzig-based enzyme producer c-LEcta GmbH is one of the fastest growing biotech companies. Among c-LEcta’s customers are manufacturers of corona vaccines as well as the who’s who of global pharmaceutical and food companies. A real success story, to which SHS has also contributed its share. Now SHS has sold its shares in c-LEcta to […]

In January 2021, SHS sold its shares in the Austrian life science supplier Single Use Support GmbH (SUS). The patent-protected liquid logistics system developed by SUS is considered the gold standard today. Among other things, SHS established a scalable corporate organisation at SUS and optimised the supply chains. During the investment phase, SUS multiplied its […]